Clinical trial · Interventional
Assessment of ONS-flavour Preference in Cancer Patients With and Without Taste Alterations
NCT05518825CI-TRIAL-00069052PREFERcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A single arm intervention study examining ONS-flavour preference in cancer patients with and without taste alterations
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oncology | — | UNRESOLVED | — |
| Taste, Altered | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fortimel/Nutridrink Compact Protein | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Fortimel/Nutridrink Compact Protein
- description
- Twice daily serving of the study product
- interventionNames
- Dietary Supplement: Fortimel/Nutridrink Compact Protein
Primary outcomes (1)
- measure
- Choice for the Fortimel/Nutridrink Compact Protein sensation flavour over the Fortimel/Nutridrink Compact Protein regular flavour
- timeFrame
- On 4 days
- description
- Subjects take one sensation flavour and one regular flavour and are asked in a direct question which flavour they prefer.
Secondary outcomes (3)
- measure
- Difference between average liking scores [score 0-10] for Fortimel/Nutridrink Compact Protein sensation flavour range versus Fortimel/Nutridrink Compact Protein regular flavour range
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Being diagnosed with cancer 2. Undergoing, or having undergone systemic anti-cancer treatment or radiotherapy in the past 12 months. 3. Age \> 18 years 4. Written informed consent Exclusion Criteria: 1. Taste and smell alterations not caused by the cancer or anti-cancer treatment 2. Galactosaemia 3. Use of thickener to be able to swallow safely 4. Allergies to any of the product ingredients or any of the flavours 5. Current prescription for ONS, enteral nutrition or parenteral nutrition 6. Diabetes mellitus Type I or Type II 7. Open sores or severe inflammation in the mouth or throat 8. Undergoing dialysis 9. Hepatic encephalopathy 10. Patients with heart failure who have symptoms of heart failure at rest and/or are unable to carry on any physical activity without discomfort 11. Known pregnancy or lactation 12. Average alcohol use of \> 21 glasses per week for men or \> 14 glasses per week for women or drug abuse in opinion of the investigator 13. Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements 14. Participation in any other studies involving food products concomitantly or within two weeks prior to entry into the study. 15. Employees of Nutricia Research and/or partners, parents, children and brothers/sisters of employees
References
Publications (0)
Data not yet available
No reference posted for this study.